State-of-the-Art Management of Colorectal Cancer: Treatment Advances and Innovation
American Society of Clinical Oncology Educational Book · 2024
DOI: 10.1200/edbk_438466 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Society of Clinical Oncology Educational Book, 2024. Verfasst von Priyadarshini S Pathak und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA. Hauptthemen laut MEDLINE: Colorectal Neoplasms. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 142 Literaturangaben.
Abstract (Originalsprache)
Colorectal cancer (CRC) remains a significant global health challenge, ranking among the leading causes of cancer-related morbidity and mortality worldwide. Recent advancements in molecular characterization have revolutionized our understanding of the heterogeneity within colorectal tumors, particularly in the context of tumor sidedness. Tumor sidedness, referring to the location of the primary tumor in either the right or left colon, has emerged as a critical factor influencing prognosis and treatment responses in metastatic CRC. Molecular underpinnings of CRC, the impact of tumor sidedness, and how this knowledge guides therapeutic decisions in the era of precision medicine have led to improved outcomes and better quality of life in patients. The emergence of circulating tumor DNA as a prognostic and predictive tool in CRC heralds promising advancements in the diagnosis and monitoring of the disease. This innovation facilitates better patient selection for exploration of additional treatment options. As the field progresses, with investigational agents demonstrating potential as future treatments for refractory metastatic CRC, new avenues for enhancing outcomes in this challenging disease are emerging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
- Department of Hematology-Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore.
- Division of Hematology, Medical Oncology, and Palliative Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI.
- University of Wisconsin Carbone Cancer Center, Madison, WI.
- McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI.
- Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
ORCID-Profile: Cheng Ean Chee
Zitieren
APA
Pathak, P. S., Chan, G., Deming, D. A., & Chee, C. E. (2024). State-of-the-Art Management of Colorectal Cancer: Treatment Advances and Innovation. American Society of Clinical Oncology Educational Book. https://doi.org/10.1200/edbk_438466
Vancouver
Pathak PS, Chan G, Deming DA, Chee CE. State-of-the-Art Management of Colorectal Cancer: Treatment Advances and Innovation. American Society of Clinical Oncology Educational Book. 2024. doi:10.1200/edbk_438466
BibTeX
@article{Pathak2024,
author = {Pathak, Priyadarshini S and Chan, Gloria and Deming, Dustin A and Chee, Cheng Ean},
title = {State-of-the-Art Management of Colorectal Cancer: Treatment Advances and Innovation},
journal = {American Society of Clinical Oncology Educational Book},
year = {2024},
doi = {10.1200/edbk_438466}
}
EUVIMED